Linda A. Parker explains the mood enhancing and anti-depressant qualities of CBD and THC.
A cutting edge paper from three cannabis friendly medical professionals—Dustin Sulak, Russel Saneto, and Bonni Goldstein—outlines case reports and the applications of cannabis medicine for epilepsy and seizure disorders.
High Times article by Martin A Lee highlights the breakthrough research on CBD, and how it has revolutionized the story of cannabis medicine.
Misinformation can masquerade as science, especially when it comes to cannabis. Adrian Devitt-Lee highlights how analysis can be skewed for a variety of factors and gives insight on how to spot faulty research data.
Many health professionals have little to no experience with cannabis therapeutics and are not able to guide people on this subject. So Project CBD has created a beginner’s guide to cannabidiol & cannabis therapeutics to address key questions of CBD users.
Our video series Cannabis Conversations interviews Dr. Ethan Russo on clinical endocannabinoid deficiency and ways to target the endocannabinoid system for therapeutic benefit.
Low-dose and high-dose treatments, protocols for chronic users, and the potential benefits of psychoactivity.
New scientific data shows that CBD interacts directly with the CB1 cannabinoid receptor in ways that are therapeutically relevant while modulating the psychoactive effects of THC. CBD lowers the ceiling on the ability of THC and endogenous cannabinoids to stimulate CB1. Cannabidiol is a profound mood-altering substance, even if it may not have a “high”.
Project CBD answers questions from our readers. This one is on vaporization and the boiling points of CBD & THC.
An excerpt from Jonathan Treasure’s new book, The Thinking Patient’s Guide to Cannabis & Cancer.